Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariam M Konaté

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Human Genomics|June 28, 2025
Prevalence and impact of molecular variation in the three-prime repair exonuclease 1 TREX1 and its implications for oncologyMarwa Shekfeh, Mariam M Konaté, Julia Krushkal
Antioxidants & Redox Signaling|February 4, 2020
Inhibiting the Activity of NADPH Oxidase in CancerMariam M Konaté, Smitha Antony, James H Doroshow
Archives of Biochemistry and Biophysics|August 16, 2019
Hydrogen peroxide-producing NADPH oxidases and the promotion of migratory phenotypes in cancerJennifer L Meitzler, Mariam M Konaté, James H Doroshow
Scientific Reports|November 12, 2022
Discovery of pathway-independent protein signatures associated with clinical outcome in human cancer cohortsMariam M Konaté, Ming-Chung Li, Lisa M McShane, et al.
Biomolecules|June 26, 2026
Serum microRNA Profiles Reflect Differentiation Status and Age in Early Gastric CancerMarwa Shekfeh, Mariam M Konaté, Hari Sankaran, et al.
Elife|September 19, 2019
Molecular function limits divergent protein evolution on planetary timescalesMariam M Konaté, Germán Plata, Jimin Park, et al.
Journal of Translational Medicine|June 23, 2021
TPM, FPKM, or Normalized Counts? A Comparative Study of Quantification Measures for the Analysis of RNA-seq Data from the NCI Patient-Derived Models RepositoryYingdong Zhao, Ming-Chung Li, Mariam M Konaté, et al.
Journal of Translational Medicine|August 5, 2024
Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenograftsMariam M Konaté, Julia Krushkal, Ming-Chung Li, et al.
Plos One|May 20, 2020
NADPH oxidase 1 is highly expressed in human large and small bowel cancersJiamo Lu, Guojian Jiang, Yongzhong Wu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 25, 2019
IL-4 and IL-17A Cooperatively Promote Hydrogen Peroxide Production, Oxidative DNA Damage, and Upregulation of Dual Oxidase 2 in Human Colon and Pancreatic Cancer CellsYongzhong Wu, Mariam M Konaté, Jiamo Lu, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Human Genomics|June 28, 2025
Prevalence and impact of molecular variation in the three-prime repair exonuclease 1 TREX1 and its implications for oncologyMarwa Shekfeh, Mariam M Konaté, Julia Krushkal
Antioxidants & Redox Signaling|February 4, 2020
Inhibiting the Activity of NADPH Oxidase in CancerMariam M Konaté, Smitha Antony, James H Doroshow
Archives of Biochemistry and Biophysics|August 16, 2019
Hydrogen peroxide-producing NADPH oxidases and the promotion of migratory phenotypes in cancerJennifer L Meitzler, Mariam M Konaté, James H Doroshow
Scientific Reports|November 12, 2022
Discovery of pathway-independent protein signatures associated with clinical outcome in human cancer cohortsMariam M Konaté, Ming-Chung Li, Lisa M McShane, et al.
Biomolecules|June 26, 2026
Serum microRNA Profiles Reflect Differentiation Status and Age in Early Gastric CancerMarwa Shekfeh, Mariam M Konaté, Hari Sankaran, et al.
Elife|September 19, 2019
Molecular function limits divergent protein evolution on planetary timescalesMariam M Konaté, Germán Plata, Jimin Park, et al.
Journal of Translational Medicine|June 23, 2021
TPM, FPKM, or Normalized Counts? A Comparative Study of Quantification Measures for the Analysis of RNA-seq Data from the NCI Patient-Derived Models RepositoryYingdong Zhao, Ming-Chung Li, Mariam M Konaté, et al.
Journal of Translational Medicine|August 5, 2024
Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenograftsMariam M Konaté, Julia Krushkal, Ming-Chung Li, et al.
Plos One|May 20, 2020
NADPH oxidase 1 is highly expressed in human large and small bowel cancersJiamo Lu, Guojian Jiang, Yongzhong Wu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 25, 2019
IL-4 and IL-17A Cooperatively Promote Hydrogen Peroxide Production, Oxidative DNA Damage, and Upregulation of Dual Oxidase 2 in Human Colon and Pancreatic Cancer CellsYongzhong Wu, Mariam M Konaté, Jiamo Lu, et al.
Pageof 2